Literature DB >> 15712188

Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.

Kirstine Oh1, Mark Redston, Robert D Odze.   

Abstract

BACKGROUND: Down-regulation of DNA repair genes has been proposed as an important mechanism of tumorigenesis in some colon cancers. This mechanism has also recently been implicated in the newly postulated hyperplastic polyp-serrated adenoma-carcinoma ("serrated") pathway of carcinogenesis, although this has never been investigated thoroughly. The aim of this study was to evaluate hMLH1, hMSH2, MGMT, as well as MIB-1, p53, and beta-catenin immunoexpression in an uncommon cohort of mixed colonic polyps that contain a combination of hyperplastic and adenomatous features (n = 21), and in some (n = 7), carcinoma as well.
DESIGN: The clinical, pathological, and immunophenotypic (hMLH1, hMSH2, MGMT, MIB-1, p53, and beta-catenin) properties of 28 mixed hyperplastic and adenomatous polyps of the colon (7 of which also contained carcinoma within the same lesion) were evaluated for the above immunopeptides in each of the different morphologic areas of the polyps, and the results were compared to traditional hyperplastic polyps, serrated adenomas, and conventional (nonserrated) adenomas.
RESULTS: Clinically, most mixed polyps with carcinoma occurred in the ascending colon (86%), and pathologically, the adenomatous component of most mixed polyps was serrated (96%). Mixed polyps, particularly those with carcinoma, showed loss of hMLH1 (33%), MGMT (37%), and even hMSH2 (11%) with significantly higher frequency compared to hyperplastic polyps, conventional adenomas, and serrated adenomas. More specifically, loss of hMLH1 and MGMT were more frequent in epithelium of higher neoplastic grade in mixed polyps. However, hMSH2 loss was only present in the adenoma component and never in the hyperplastic or carcinomatous areas of these polyps. Defects in MIB-1 proliferation indices and p53 were not significantly different among the same epithelial components in each of the polyp groups. However, conventional adenomas showed significantly higher rates of nuclear beta -catenin staining (100%) in comparison to the adenomatous component of mixed polyps (60%).
CONCLUSIONS: Loss of hMLH1 and MGMT play a prominent role in the serrated pathway of carcinogenesis in the colon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712188     DOI: 10.1016/j.humpath.2004.10.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma.

Authors:  John J Liang; Sadir Alrawi; Dongfeng Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.

Authors:  Charly Liddell; Laure Droy-Dupré; Sylvie Métairie; Fabrice Airaud; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Mod Pathol       Date:  2017-04-21       Impact factor: 7.842

4.  Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma.

Authors:  Hailong Zhu; Huali Qin; Ziling Huang; Shuai Li; Xuyou Zhu; Jian He; Jing Yang; Xiaoting Yu; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.

Authors:  Kyung-Hwa Lee; Ji-Shin Lee; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Jae-Hyuk Lee
Journal:  Langenbecks Arch Surg       Date:  2011-06-25       Impact factor: 3.445

Review 6.  Risk factors for serrated polyps of the colorectum.

Authors:  Tanvir R Haque; Patrick T Bradshaw; Seth D Crockett
Journal:  Dig Dis Sci       Date:  2014-07-17       Impact factor: 3.199

7.  Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.

Authors:  P Minoo; K Baker; R Goswami; G Chong; W D Foulkes; A R Ruszkiewicz; M Barker; D Buchanan; J Young; J R Jass
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

8.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

9.  Serrated colonic polyps in a teaching hospital in Saudi Arabia: prevalence and review of classification.

Authors:  Rana Bokhary
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

Review 10.  Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management.

Authors:  Christophe Rosty; David G Hewett; Ian S Brown; Barbara A Leggett; Vicki L J Whitehall
Journal:  J Gastroenterol       Date:  2012-12-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.